Interim CCO for Aptamer Group
Aptamer Group, a developer of novel Optimer binders, has appointed Derek Smith as Interim Chief Commercial Officer.
Smith joined the company in 2018 as Director of Global Sales and has since overseen the development and implementation of the its global sales strategy, securing contracts across all three business divisions, including with a number of major pharmaceutical companies. Prior to joining Aptamer Group, he held senior sales positions at various UK healthcare companies.
Headquartered in York, UK, Aptamer Group develops custom affinity binders through its proprietary Optimer platform to enable new approaches in therapeutics, diagnostics and research applications.
Optimer binders are oligonucleotide affinity ligands that can function as an antibody alternative. They are engineered to address many of the issues found with alternative affinity molecules, such as antibodies, and offer new solutions to bioprocessing, diagnostic and pharmaceutical scientists.